The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology--Head and Neck Surgery

Volumn 119, Issue 10, 1993, Pages 1118-1122

  Field, John K ^a   Pavelic, Zlatko P ^b   Spandidos, Demetrios A ^c   Stambrook, Peter J ^b   Jones, Andrew S ^a   Gluckman, Jack L ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c INSTITUTE OF BIOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ALCOHOL; ANTIBODY; ASPARTATE CARBAMOYLTRANSFERASE; CARBAMOYL PHOSPHATE SYNTHASE; CARCINOGEN; DIHYDROOROTASE; DNA; GENE PRODUCT; MUTAGENIC AGENT; PROTEIN P53; SPARFOSIC ACID;

ALCOHOL CONSUMPTION; ARTICLE; CODON; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MODEL; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; MUTATION; PROGNOSIS;

EID: 0027371364     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1993.01880220064009     Document Type: Article

References (50)

1. Holstein M, Sidransky D, Vogelstein B, Harris C. p53 Mutations in human cancer. Science. 1991;253:49-53.
2. Bartek J, Barkova J, Vojtesek B, et al. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer. 1990;46:839-844.
3. Lane DP, Crawford LV. T-antigen is bound to a host protein in SV40 transformed cells. Nature. 1979;278:261-263.
4. Finley CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989;57:1083-1093.
5. Hinds P, Finlay C, Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol. 1989;63:739-746.
6. Weinberg RA. Tumor suppressor genes. Science. 1991;254:1138-1146.
7. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990's. Cancer Res. 1991;51:5023-5044.
8. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76-79.
9. Oliner JD, Kinzler KW, Melzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcoma. Nature. 1992;358: 15-16.
10. Farmer G, Burgonetti J, Zhu H, et al. Wild-type p53 activates transcription in vitro. Nature. 1992;358:83-86.
11. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992;70:937-948.
12. Lane DP. p53, Guardian of the genome. Nature. 1992;358:15-16.
13. Lane DP. Reply to checkpoint policing by p53. Nature. 1992;359:486-487.
14. Windle BE, Wahl GM. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat Res. 1992;276:199-224.
15. Lane DP, Benchimol S. p53: Oncogene or anti-oncogene? Genes Dev. 1990; 4:1-8.
16. Chibia I, Takahashi T, Nau M, et al. Mutations in the p53 gene are frequent in primary, resected non—small cell lung cancer. Oncogene. 1990;5:1603-1610.
17. Suzuki H, Takahashi T, Kuroishi T, et al. p53 Mutations in non—small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 1992;52:734-736.
18. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991;350:429-431.
19. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991;350:427-428.
20. Field JK, Malliri A, Jones AJ, Spandidos DA. Mutations in the p53 gene at codon 249 are rare in squamous cell carcinoma of the head and neck. Int J Oncol. 1992;1:253-256.
21. Field JK, Spandidos DA, Malliri A, Yiagnisis M, Gosney JR, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991;64:573-577.
22. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 1991;6:1785-1789.
23. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol. 1992;166: 389-394.
24. Langdon JD, Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg. 1992;30:214-220.
25. Dolcetti R, Doglioni C, Maestro R, et al. p53 Over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer. 1992;52:178-182.
26. Watling DL, Gown AM, Coltrera MD. Overexpression of p53 in head and neck cancer. Head Neck. 1992;14:437-444.
27. Pavelic ZP, Gluckman JL, Gapany M, et al. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res. 1992;12:1389-1394.
28. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 1992;7:927-933.
29. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992;7:1159-1166.
30. Brachman DG, Graves D, Bokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 1992;52:4832-4836.
31. Somers KD, Merrick MA, Lopez ME, Incognito LA, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52:5997-6000.
32. Sakai E, Rikimura K, Ueda M, et al. The p53 tumour suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer. 1992;52: 867-729.
33. Field JK, Zoumpourlis V, Spandidos DA, et al. p53 Expression and mutations in squamous cell carcinoma of the head and neck: correlates with the patient's use of tobacco and alcohol. Cancer Detect Prev. In press.
34. Munck-Wickland E, Edstrom S, Jungmark E, et al. p53 Immunostaining in cis lesions of the larynx. Cancer Detect Prev. 1992;17:89.
35. Field JK, Malliri A, Butt SA, et al. p53 Over-expression in end stage squamous cell carcinomas of the head and neck: correlates with a very poor clinical outcome. Int J Oncol. 1993;3:431-435.
36. Sauter ER, Ridge JA, Gordon J, Eisenberg BL. p53 Over-expression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg. 1992;164:651-653.
37. Jones AS, Phillips DE, Field JK. A phase II study of cisplatinum versus cisplatinum and nifedipine in end stage carcinoma of the head and neck. Clin Otol. In press.
38. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res. 1977;37:4608-4622.
39. Schmidt W, Popham RE. The role of drinking and smoking in mortality from cancer and other causes in male alcoholics. Cancer. 1981;47:1030-1035.
40. McCoy DG, Wynder EL. Etiological and preventive implications in alcohol carcinogenesis. Cancer Res. 1979;39:2844-2850.
41. Field JK, Spandidos DA, Stell PM. Over-expression of the p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet. 1992;339:502-503.
42. Baker SJ, Preisinger AC, Milburn Jessup J, et al. p53 Gene mutations occur in combination with 17p allelic delections as late events in colorectal tumorigenesis. Cancer Res. 1990;50:7717-7722.
43. Purdie CA, O'Grady J, Piris J, Wylie AH, Bird CC. p53 Expression in colorectal tumors. Am J Pathol. 1991;138:807-813.
44. Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene. 1991;6:413-421.
45. Ostrowski JL, Sawan A, Henry L, et al. p53 Expression human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol. 1991;164:75-81.
46. Papadakis E, Malliri A, Linardopoulos S, Karaiossifidi H, Field JK, Spandidos DA. ras and p53 expression in non—small cell lung cancer patients: p53 overexpression correlates with a poor prognosis. Int J Oncol. 1992;1:403-413.
47. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 1992;52:4828-4831.
48. Poller DN, Hutchings CE, Galae M, et al. p53 Protein expression in human breast carcinoma: relationship to expression epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. Br J Cancer. 1992; 66:583-588.
49. Milner BJ, Allan LA, Eccles DM, et al. p53 Mutation is a common genetic event in ovarian carcinoma. Cancer Res. 1993;53:2128-2132.
50. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer Oral Oncol. 1992;28B:67-76.